RESEARCH LIBRARY

Alzheimer's & Dementia, 14: 925-932

The purpose of this survey is to understand how the prevalence of beliefs, attitudes, and expectations about Alzheimer's disease dementia in the public could inform strategies to mitigate stigma.

Med Educ, 52: 359-361

Focusing specifically on examples set in the context of movement from Bachelor's level undergraduate programmes to enrolment in medical school, this publication argues that a great deal of what happens on college campuses today, curricular and otherwise, is (in)directly driven by the not‐so‐invisible hand of the medical education enterprise.

Educational Measurement: Issues and Practice, 37: 40-45

This simulation study demonstrates that the strength of item dependencies and the location of an examination systems’ cut‐points both influence the accuracy (i.e., the sensitivity and specificity) of examinee classifications. Practical implications of these results are discussed in terms of false positive and false negative classifications of test takers.

Qual Life Res 27, 1711–1720 (2018)

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.

Medical Care: April 2017 - Volume 55 - Issue 4 - p 436-441

The objective of this study is to identify modifiable factors that improve the reliability of ratings of severity of health care–associated harm in clinical practice improvement and research.